Skip to main content
Top
Published in: Lung 1/2015

01-02-2015

Physical Activity and the Frequency of Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease

Authors: M. Schönmann, N. A. Sievi, C. F. Clarenbach, T. Brack, M. Brutsche, M. Frey, S. Irani, J. D. Leuppi, J. Ruediger, O. Senn, R. Thurnheer, M. Kohler

Published in: Lung | Issue 1/2015

Login to get access

Abstract

Purpose

Acute exacerbations (AE) in patients with COPD are associated with a decline in lung function, increased risk of hospitalization, and mortality. In this cross-sectional study we tested whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.

Methods

In 210 patients with COPD (67 % men; mean (SD) age: 63 (8) years) enrolled in The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland (TOPDOCS) physical activity (PA) (steps per day, physical activity level, (PAL)), exercise capacity (6-min walking distance, (6MWD)), comorbidities, lung function, and medication were assessed. Differences between COPD patients with frequent (≥2 year) and infrequent (0–1 year) exacerbations were assessed. Univariate and multivariate analyses were performed to investigate whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.

Results

Patients with frequent AE had a significantly lower FEV1 and 6MWD compared to patients with infrequent AE. In univariate analysis, the number of exacerbations was inversely associated with FEV1, 6MWD, BMI, and smoking status while there was a positive association with RV/TLC and combined inhaled medication. However, there was no significant association with PAL and steps per day. In multivariate analysis, FEV1 and the use of combined inhaled medication were independently associated with the number of AE, after correction for covariates.

Conclusions

The findings of this study imply that FEV1, independent of inhaled medication, is significantly associated with COPD exacerbations. Neither physical activity nor exercise capacity was independently associated with COPD exacerbations.
Literature
2.
go back to reference Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555PubMedCrossRef Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555PubMedCrossRef
3.
go back to reference Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138PubMedCrossRef Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138PubMedCrossRef
4.
go back to reference Anzueto A, Leimer I, Kesten S (2009) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chronic Obstr Pulm Dis 4:245–251 Anzueto A, Leimer I, Kesten S (2009) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chronic Obstr Pulm Dis 4:245–251
5.
go back to reference Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164(3):358–364PubMedCrossRef Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164(3):358–364PubMedCrossRef
6.
go back to reference Cote CG, Dordelly LJ, Celli BR (2007) Impact of COPD exacerbations on patient-centered outcomes. Chest 131(3):696–704PubMedCrossRef Cote CG, Dordelly LJ, Celli BR (2007) Impact of COPD exacerbations on patient-centered outcomes. Chest 131(3):696–704PubMedCrossRef
7.
go back to reference Vestbo J, Edwards LD, Scanlon PD et al (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13):1184–1192PubMedCrossRef Vestbo J, Edwards LD, Scanlon PD et al (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13):1184–1192PubMedCrossRef
8.
go back to reference Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122PubMedCentralPubMed Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122PubMedCentralPubMed
9.
go back to reference Seemungal TA, Donaldson GC, Paul EA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(5 Pt 1):1418–1422PubMedCrossRef Seemungal TA, Donaldson GC, Paul EA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(5 Pt 1):1418–1422PubMedCrossRef
10.
go back to reference Connors AF Jr., Dawson NV, Thomas C et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 154(4 Pt 1):67–959 Connors AF Jr., Dawson NV, Thomas C et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 154(4 Pt 1):67–959
11.
go back to reference Gunen H, Hacievliyagil SS, Kosar F et al (2005) Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26(2):234–241PubMedCrossRef Gunen H, Hacievliyagil SS, Kosar F et al (2005) Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26(2):234–241PubMedCrossRef
12.
go back to reference Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931PubMedCentralPubMedCrossRef Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931PubMedCentralPubMedCrossRef
13.
go back to reference Garcia-Rio F, Rojo B, Casitas R et al (2012) Prognostic value of the objective measurement of daily physical activity in COPD patients. Chest 142(2):338–346PubMedCrossRef Garcia-Rio F, Rojo B, Casitas R et al (2012) Prognostic value of the objective measurement of daily physical activity in COPD patients. Chest 142(2):338–346PubMedCrossRef
14.
go back to reference Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778PubMedCentralPubMedCrossRef Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778PubMedCentralPubMedCrossRef
15.
go back to reference Garcia-Aymerich J, Serra I, Gomez FP et al (2009) Physical activity and clinical and functional status in COPD. Chest 136(1):62–70PubMedCrossRef Garcia-Aymerich J, Serra I, Gomez FP et al (2009) Physical activity and clinical and functional status in COPD. Chest 136(1):62–70PubMedCrossRef
16.
go back to reference Casaburi R (2011) Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc 8(4):334–337PubMedCrossRef Casaburi R (2011) Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc 8(4):334–337PubMedCrossRef
17.
go back to reference Garcia-Aymerich J, Farrero E, Felez MA et al (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58(2):100–105PubMedCentralPubMedCrossRef Garcia-Aymerich J, Farrero E, Felez MA et al (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58(2):100–105PubMedCentralPubMedCrossRef
18.
go back to reference Seidel D, Cheung A, Suh ES et al (2012) Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16(8):1015–1019PubMedCrossRef Seidel D, Cheung A, Suh ES et al (2012) Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16(8):1015–1019PubMedCrossRef
19.
go back to reference Donaldson GC, Wilkinson TM, Hurst JR et al (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(5):446–452PubMedCrossRef Donaldson GC, Wilkinson TM, Hurst JR et al (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(5):446–452PubMedCrossRef
20.
go back to reference Lichtman SW, Pisarska K, Berman ER et al (1992) Discrepancy between self-reported and actual caloric-intake and exercise in obese subjects. N Engl J Med 327(27):1893–1898PubMedCrossRef Lichtman SW, Pisarska K, Berman ER et al (1992) Discrepancy between self-reported and actual caloric-intake and exercise in obese subjects. N Engl J Med 327(27):1893–1898PubMedCrossRef
21.
go back to reference van Gestel AJ, Clarenbach CF, Stowhas AC et al (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS One 7(11):e48081PubMedCentralPubMedCrossRef van Gestel AJ, Clarenbach CF, Stowhas AC et al (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS One 7(11):e48081PubMedCentralPubMedCrossRef
22.
go back to reference Waschki B, Spruit MA, Watz H et al (2012) Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 106(4):522–530PubMedCrossRef Waschki B, Spruit MA, Watz H et al (2012) Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 106(4):522–530PubMedCrossRef
23.
go back to reference Manini TM, Everhart JE, Patel KV et al (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296(2):171–179PubMedCrossRef Manini TM, Everhart JE, Patel KV et al (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296(2):171–179PubMedCrossRef
24.
go back to reference Scheers T, Philippaerts R, Lefevre J (2012) Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear armband complemented with an electronic diary. Int J Behav Nutr Phys Act 9(1):71PubMedCentralPubMedCrossRef Scheers T, Philippaerts R, Lefevre J (2012) Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear armband complemented with an electronic diary. Int J Behav Nutr Phys Act 9(1):71PubMedCentralPubMedCrossRef
25.
go back to reference ATS (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef ATS (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef
26.
go back to reference Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236–1241PubMedCrossRef Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236–1241PubMedCrossRef
27.
go back to reference Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338PubMedCrossRef
28.
go back to reference Boon RM, Hamlin MJ, Steel GD et al (2010) Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry. Br J Sports Med 44(10):741–746PubMedCrossRef Boon RM, Hamlin MJ, Steel GD et al (2010) Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry. Br J Sports Med 44(10):741–746PubMedCrossRef
29.
go back to reference Ekelund U, Sepp H, Brage S et al (2006) Criterion-related validity of the last 7-day, short form of the international physical activity questionnaire in Swedish adults. Public Health Nutr 9(2):258–265PubMedCrossRef Ekelund U, Sepp H, Brage S et al (2006) Criterion-related validity of the last 7-day, short form of the international physical activity questionnaire in Swedish adults. Public Health Nutr 9(2):258–265PubMedCrossRef
30.
go back to reference Watz H, Waschki B, Meyer T et al (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262–272PubMedCrossRef Watz H, Waschki B, Meyer T et al (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262–272PubMedCrossRef
31.
go back to reference Carr SJ, Goldstein RS, Brooks D (2007) Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 132(1):127–134PubMedCrossRef Carr SJ, Goldstein RS, Brooks D (2007) Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 132(1):127–134PubMedCrossRef
32.
go back to reference McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214PubMedCentralPubMedCrossRef McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214PubMedCentralPubMedCrossRef
33.
go back to reference Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99(18):2434–2439PubMedCrossRef Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99(18):2434–2439PubMedCrossRef
Metadata
Title
Physical Activity and the Frequency of Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
Authors
M. Schönmann
N. A. Sievi
C. F. Clarenbach
T. Brack
M. Brutsche
M. Frey
S. Irani
J. D. Leuppi
J. Ruediger
O. Senn
R. Thurnheer
M. Kohler
Publication date
01-02-2015
Publisher
Springer US
Published in
Lung / Issue 1/2015
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9673-7

Other articles of this Issue 1/2015

Lung 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.